Agilent said this week that it will collaborate with Australia's Florey Institute of Neuroscience and Mental Health on methods for measuring metals at the protein level in tissue affected by neurodegenerative diseases including motor neuron, Parkinson's, and Alzheimer's.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.